Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates...

Area of Science:

• Immunology
• Clinical Medicine
• Cell Biology

Background:

• Common Variable Immunodeficiency (CVID) is a heterogeneous syndrome characterized by impaired immunoglobulin production.
• Current functional classifications for CVID are time-consuming and lack predictive value.

Purpose of the Study:

• To propose and validate a novel classification system for CVID patients based on quantitative B cell subsets (naive/memory) defined by IgD and CD27 expression.
• To correlate this new classification with clinical manifestations and explore underlying pathogenic mechanisms.

Main Methods:

• Categorization of 57 CVID patients into three groups (MB0, MB1, MB2) based on IgD and CD27 expression on B cells.
• Analysis of B cell activation markers and T cell activation markers.
• Correlation of B cell phenotypes with clinical data including splenomegaly, lymphoid proliferation, granulomatous disease, and autoimmunity.

Main Results:

• Three distinct patient groups were identified: MB2 (normal memory B cells), MB1 (defective switched memory B cells), and MB0 (nearly absent memory B cells).
• Group MB1 exhibited B cell down-regulation of activation markers and T cell up-regulation of activation markers.
• The classification correlated with clinical features, with higher prevalence of splenomegaly, lymphoid proliferation, and granulomatous disease in MB0 and MB1 groups.

Conclusions:

• A novel classification of CVID based on B cell subsets (MB0, MB1, MB2) provides a more clinically relevant categorization.
• This classification aids in understanding the diverse clinical phenotypes of CVID and suggests distinct underlying B cell dysfunction mechanisms.